HEMOPHILIA A OR B

Clinical trials for HEMOPHILIA A OR B explained in plain language.

Never miss a new study

Get alerted when new HEMOPHILIA A OR B trials appear

Sign up with your email to follow new studies for HEMOPHILIA A OR B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New weekly shot aims to prevent bleeding in hemophilia patients

Disease control Recruiting now

This Phase 3 study is testing a drug called KN057, given as a weekly injection under the skin, to prevent bleeding in people with hemophilia A or B (with or without inhibitors). The trial will enroll 70 males aged 12 to 65 and will monitor safety and how well the drug works over …

Matched conditions: HEMOPHILIA A OR B

Phase: PHASE3 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

HEMOPHILIA A OR B

Get alerted when new HEMOPHILIA A OR B trials appear

New weekly shot aims to prevent bleeding in hemophilia patients